Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00051740 · ClinicalTrials.gov registry record · NA
Treating Thought Problems in Patients With Schizophrenia
A NA study, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT00051740: Completed NA study, sponsored by The University of Texas Health Science Center at San Antonio.
NCT00051740 is a NA study that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 120 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00051740, a NA study, has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
This study will compare Cognitive Adaptation Training (CAT) to minimal schizophrenia treatment. This study will also determine whether the intensity of CAT can be reduced and still provide benefits to patients with schizophrenia.
Primary Outcome
compare Cognitive Adaptation Training (CAT) to minimal schizophrenia treatment.
Interventions
- BEHAVIORAL Cognitive Adaptation Therapy (CAT)
- BEHAVIORAL Minimal Environmental Supports (MES)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2002-02 |
| Est. Completion | 2008-10 |
| Phase | NA |
What the finished NCT00051740 record still lists
NCT00051740 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which Cognitive Adaptation Therapy (CAT) is the first listed.
NCT00051740 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00051740 about?
NCT00051740 is a clinical study titled "Treating Thought Problems in Patients With Schizophrenia". This study will compare Cognitive Adaptation Training (CAT) to minimal schizophrenia treatment. This study will also determine whether the intensity of CAT can be reduced and still provide benefits to patients with schizophrenia.
What is the current status of trial NCT00051740?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2002-02. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00051740?
The interventions under investigation include: Cognitive Adaptation Therapy (CAT) (BEHAVIORAL), Minimal Environmental Supports (MES) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00051740?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00051740's enrollment target sits among peer trials
120 762nd of 2000 higher than 1,198 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia